Distribution growth is a key part of our business strategy, but were also seeing our velocities continue to increase as our ACV jumps up, proving the placements were earning are healthy and profitable. Supergut Riding GLP-1 Train Into New Distribution Channels Supergut is seeing returns on its alignment GLP-1 weight loss trend
Statistically significant reduced incidence seen across multiple large cohorts For this analysis, the researchers looked at health records from 111,646 women ages 45 to 80 with a body mass index (BMI) of 25 or above (the overweight threshold) who had breast imaging and a documented outcome in the Penn Medicine EHR between January 2022 and June 2025
What to Expect With Semaglutide In contrast to one-size-fits-all approaches, we provide all patients with a custom plan tailored to their individual needs
Jensterle M, Salamun V, Kocjan T, Vrtacnik Bokal E, Janez A (2015) Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study
GLP-1 mimics glucagon, a naturally occurring hormone that helps regulate blood sugar levels and appetite
Delivery lead-time 4